XJPX
3540
Market cap91mUSD
Dec 12, Last price
1,493.00JPY
Name
CI Medical Co Ltd
Chart & Performance
P/E
2.38
P/S
0.22
EPS
626.71
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
18.60%
Revenues
67.49b
+47.92%
Net income
6.27b
+200.86%
CFO
6.15b
P
Dividend
Dec 27, 202412.5302 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 2000 and based in Hakusan, Japan, C.I. Medical Co.,Ltd. is an enterprise focused on the development, manufacturing, and marketing of dental and oral health products throughout Japan. Their product range includes various toothbrushes and other personal dental care essentials, which are also offered for direct purchase through mail order. Additionally, the company supplies advanced solutions to dental facilities, such as milling equipment, imaging scanners, and specialized software applications, alongside trading in sophisticated clinical dental machinery. C.I. Medical caters to a wide array of clients, including medical cooperatives, private dental clinics, professional dental associations, health centers, dental colleges, hospitals, veterinary practices, nursing and care facilities, and wholesale dental dealers.
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||